Summarizing, the B7-2-deficient NOD mouse mirrors the slowly and chronic progressive nature of CIDP, does not require immunization, and has been successfully used to study mechanisms and test several novel therapies of CIDP. The gene discussed is CD86; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.